These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

766 related items for PubMed ID: 25994249

  • 1. D-dimer for prediction of long-term outcome in cryptogenic stroke patients with patent foramen ovale.
    Kim YD, Song D, Nam HS, Lee K, Yoo J, Hong GR, Lee HS, Nam CM, Heo JH.
    Thromb Haemost; 2015 Aug 31; 114(3):614-22. PubMed ID: 25994249
    [Abstract] [Full Text] [Related]

  • 2. Predictors of recurrent events in patients with cryptogenic stroke and patent foramen ovale within the CLOSURE I (Evaluation of the STARFlex Septal Closure System in Patients With a Stroke and/or Transient Ischemic Attack Due to Presumed Paradoxical Embolism Through a Patent Foramen Ovale) trial.
    Elmariah S, Furlan AJ, Reisman M, Burke D, Vardi M, Wimmer NJ, Ling S, Chen X, Kent DM, Massaro J, Mauri L, CLOSURE I Investigators.
    JACC Cardiovasc Interv; 2014 Aug 31; 7(8):913-20. PubMed ID: 25147037
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Long-term experience and outcomes with transcatheter closure of patent foramen ovale.
    Inglessis I, Elmariah S, Rengifo-Moreno PA, Margey R, O'Callaghan C, Cruz-Gonzalez I, Baron S, Mehrotra P, Tan TC, Hung J, Demirjian ZN, Buonanno FS, Ning M, Silverman SB, Cubeddu RJ, Pomerantsev E, Schainfeld RM, Dec GW, Palacios IF.
    JACC Cardiovasc Interv; 2013 Nov 31; 6(11):1176-83. PubMed ID: 24262618
    [Abstract] [Full Text] [Related]

  • 6. Risk of recurrent ischemic stroke in patients with patent foramen ovale: The role of D-dimer.
    Park S, Kwon B, Oh JK, Song JK, Lee JS, Kwon SU.
    J Stroke Cerebrovasc Dis; 2023 Sep 31; 32(9):107246. PubMed ID: 37536016
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Long-term propensity score-matched comparison of percutaneous closure of patent foramen ovale with medical treatment after paradoxical embolism.
    Wahl A, Jüni P, Mono ML, Kalesan B, Praz F, Geister L, Räber L, Nedeltchev K, Mattle HP, Windecker S, Meier B.
    Circulation; 2012 Feb 14; 125(6):803-12. PubMed ID: 22238228
    [Abstract] [Full Text] [Related]

  • 10. Patent foramen ovale closure following cryptogenic stroke or transient ischaemic attack: Long-term follow-up of 301 cases.
    Mirzaali M, Dooley M, Wynne D, Cooter N, Lee L, Haworth P, Saha R, Gainsborough N, Hildick-Smith D.
    Catheter Cardiovasc Interv; 2015 Nov 15; 86(6):1078-84. PubMed ID: 26105198
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Long-term results after fluoroscopy-guided closure of patent foramen ovale for secondary prevention of paradoxical embolism.
    Wahl A, Kunz M, Moschovitis A, Nageh T, Schwerzmann M, Seiler C, Mattle HP, Windecker S, Meier B.
    Heart; 2008 Mar 15; 94(3):336-41. PubMed ID: 17639093
    [Abstract] [Full Text] [Related]

  • 14. Transesophageal echocardiography in cryptogenic stroke and patent foramen ovale: analysis of putative high-risk features from the risk of paradoxical embolism database.
    Wessler BS, Thaler DE, Ruthazer R, Weimar C, Di Tullio MR, Elkind MS, Homma S, Lutz JS, Mas JL, Mattle HP, Meier B, Nedeltchev K, Papetti F, Di Angelantonio E, Reisman M, Serena J, Kent DM.
    Circ Cardiovasc Imaging; 2014 Jan 15; 7(1):125-31. PubMed ID: 24214884
    [Abstract] [Full Text] [Related]

  • 15. Patent foramen ovale and cryptogenic stroke.
    Nakanishi K, Yoshiyama M, Homma S.
    Trends Cardiovasc Med; 2017 Nov 15; 27(8):575-581. PubMed ID: 28709812
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Implications of detection of foramen ovale patent after cryptogenic ischemic stroke.
    Marinheiro R, Parreira L, Amador P, Silvestre I, Antunes C, Caria R.
    J Echocardiogr; 2019 Mar 15; 17(1):44-51. PubMed ID: 30008156
    [Abstract] [Full Text] [Related]

  • 19. Age as a determinant of adverse events in medically treated cryptogenic stroke patients with patent foramen ovale.
    Homma S, DiTullio MR, Sacco RL, Sciacca RR, Mohr JP, PICSS Investigators.
    Stroke; 2004 Sep 15; 35(9):2145-9. PubMed ID: 15232117
    [Abstract] [Full Text] [Related]

  • 20. Prevalence of Pelvic Vein Pathology in Patients with Cryptogenic Stroke and Patent Foramen Ovale Undergoing MRV Pelvis.
    Osgood M, Budman E, Carandang R, Goddeau RP, Henninger N.
    Cerebrovasc Dis; 2015 Sep 15; 39(3-4):216-23. PubMed ID: 25791718
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 39.